Exuma Biotech Company
EXUMA Biotech is a clinical-stage biotechnology company that focuses on discovering and developing CAR-T cell products for solid tumors.
Total Funding:
107000000
Funding Status:
Early Stage Venture
Last Funding Date:
2021-12-21
Founded Date:
2015-01-01
Last Funding Type:
Series B
Estimated Revenue:
$1M to $10M
Industry:
CAR-T
Headquarters:
Grand Cayman, Midland, Cayman Islands
Investors Number:
7